Skip to content

ALDER BIOPHARMACEUTICALS INC

CIK 0001423824

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q2 Aug 2019
Net Income (TTM)
−$305.65M
−445.3% YoY Q2 Aug 2019
EPS Diluted (TTM)
−$3.23
−438.3% YoY Q2 Aug 2019
Gross Margin
—
Q2 Aug 2019
Operating Margin
—
Q2 Aug 2019
Net Margin
—
Q2 Aug 2019
Free Cash Flow (TTM)
−$253.15M
Q2 Aug 2019
Cash
$88.38M
Q2 Aug 2019
Total Debt
$188.32M
Q2 Aug 2019
Shares Outstanding
83.64M sh
Q2 Aug 2019

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings